Aesthetic Medicine Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global aesthetic medicine market size is expected to touch USD 155.67 Billion by 2030, from USD 75.90 Billion in 2022, growing with a significant CAGR of 9.5% from 2022 to 2030. 

The aesthetic medicine report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global aesthetic medicine in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global aesthetic medicine market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global aesthetic medicine during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons). 

Sample Link @ https://www.precedenceresearch.com/sample/1667

 Report Scope of the Aesthetic Medicine Market

Report Coverage	Details
Market Size by 2030	USD 155.67 Billion
Growth Rate from 2022 to 2030	CAGR of 9.5%
North America Market Share in 2021	36%
Non-invasive Procedures Segment Market Share in 2021	51%
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Procedure, Product, Application, End-User, Gender, Route of Administration, Geography

This study covers a detailed segmentation of the global aesthetic medicine market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global aesthetic medicine market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

• AbbVie Inc.
• Galderma
• Alma Lasers
• Cynosure
• Johnson & Johnson Private Limited
• Lumenis Be Ltd.
• Solta Medical
• Candela Medical
• Hologic, Inc.
• Dentsply Sirona

Market Segmentation

 By Procedure Type

• Non-Invasive Procedure
  • Botox Injections
  • Microdermabrasion
  • Soft Tissue Fillers
  • Laser Hair Removal
  • Chemical Peel
  • Others
• Invasive Procedure
  • Liposuction
  • Nose Reshaping
  • Breast Augmentation
  • Tummy Tuck
  • Eyelid Surgery
  • Others

By Product Type

• Energy-Based Devices
• Laser-based Aesthetic Device
• Radiofrequency (RF)-based Aesthetic Device
• Light-based Aesthetic Device
• Ultrasound Aesthetic Device
• Others
• Implants
• Facial Implants
• Breast Implants
• Others
• Anti-Wrinkle Products
• Botulinum Toxin
• Dermal Fillers
• Others

By Application

• Surgical
• Non-Surgical

By End-User

• Medical Spas and Beauty Centres
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Use

By Gender

• Males
• 18 years and below
• 19-34 years
• 35-50 years
• 51-64 years
• 65 years and above
• Females
• 18 years and below
• 19-34 years
• 35-50 years
• 51-64 years
• 65 years and above

By Route of Administration

• Oral
• Topical

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global aesthetic medicine report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global aesthetic medicine market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Route of Administration Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Aesthetic Medicine Market 

5.1. COVID-19 Landscape: Aesthetic Medicine Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Aesthetic Medicine Market, By Product Type

8.1. Aesthetic Medicine Market, by Product Type, 2022-2030

8.1.1. Energy-Based Devices

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Implants

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Anti-Wrinkle Products

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Dermal Fillers

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Botulinum Toxin

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Aesthetic Medicine Market, By Procedure Type

9.1. Aesthetic Medicine Market, by Procedure Type, 2022-2030

9.1.1. Non-Invasive Procedure

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Invasive Procedure

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Aesthetic Medicine Market, By Application Type 

10.1. Aesthetic Medicine Market, by Application Type, 2022-2030

10.1.1. Surgical

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Non-Surgical

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Aesthetic Medicine Market, By End-User Type

11.1. Aesthetic Medicine Market, by End-User Type, 2022-2030

11.1.1. Medical Spas and Beauty Centres

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Hospitals and Clinics

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Ambulatory Surgical Centers

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Aesthetic Medicine Market, By Gender

12.1. Aesthetic Medicine Market, by Gender, 2022-2030

12.1.1. Males

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Females

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Aesthetic Medicine Market, By Route of Administration

13.1. Aesthetic Medicine Market, by Procedure Type, 2022-2030

13.1.1. Oral

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Topical

13.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Aesthetic Medicine  Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.1.3. Market Revenue and Forecast, by Application (2017-2030)

14.1.4. Market Revenue and Forecast, by End-User (2017-2030)

14.1.5. Market Revenue and Forecast, by Gender (2017-2030)

14.1.6. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.7.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.1.7.3. Market Revenue and Forecast, by Application (2017-2030)

14.1.7.4. Market Revenue and Forecast, by End-User (2017-2030)

14.1.8. Market Revenue and Forecast, by Gender (2017-2030)

14.1.8.1. Market Revenue and Forecast, by Route of Administration (2017-2030) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Application (2017-2030)

14.1.9.4. Market Revenue and Forecast, by End-User (2017-2030)

14.1.10. Market Revenue and Forecast, by Gender (2017-2030)

14.1.11. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.2.3. Market Revenue and Forecast, by Application (2017-2030)

14.2.4. Market Revenue and Forecast, by End-User (2017-2030) 

14.2.5. Market Revenue and Forecast, by Gender (2017-2030)

14.2.6. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Application (2017-2030)

14.2.9. Market Revenue and Forecast, by End-User (2017-2030) 

14.2.10. Market Revenue and Forecast, by Gender (2017-2030)

14.2.10.1. Market Revenue and Forecast, by Route of Administration (2017-2030) 

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Application (2017-2030)

14.2.12. Market Revenue and Forecast, by End-User (2017-2030)

14.2.13. Market Revenue and Forecast, by Gender (2017-2030)

14.2.14. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.15.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.2.15.3. Market Revenue and Forecast, by Application (2017-2030)

14.2.15.4. Market Revenue and Forecast, by End-User (2017-2030)

14.2.16. Market Revenue and Forecast, by Gender (2017-2030)

14.2.16.1. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.17.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.2.17.3. Market Revenue and Forecast, by Application (2017-2030)

14.2.17.4. Market Revenue and Forecast, by End-User (2017-2030)

14.2.18. Market Revenue and Forecast, by Gender (2017-2030)

14.2.18.1. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.3.3. Market Revenue and Forecast, by Application (2017-2030)

14.3.4. Market Revenue and Forecast, by End-User (2017-2030)

14.3.5. Market Revenue and Forecast, by Gender (2017-2030)

14.3.6. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.7.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.3.7.3. Market Revenue and Forecast, by Application (2017-2030)

14.3.7.4. Market Revenue and Forecast, by End-User (2017-2030)

14.3.8. Market Revenue and Forecast, by Gender (2017-2030)

14.3.9. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Application (2017-2030)

14.3.10.4. Market Revenue and Forecast, by End-User (2017-2030)

14.3.11. Market Revenue and Forecast, by Gender (2017-2030)

14.3.11.1. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.12.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.3.12.3. Market Revenue and Forecast, by Application (2017-2030)

14.3.12.4. Market Revenue and Forecast, by End-User (2017-2030)

14.3.12.5. Market Revenue and Forecast, by Gender (2017-2030)

14.3.12.6. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.13.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.3.13.3. Market Revenue and Forecast, by Application (2017-2030)

14.3.13.4. Market Revenue and Forecast, by End-User (2017-2030)

14.3.13.5. Market Revenue and Forecast, by Gender (2017-2030)

14.3.13.6. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.4.3. Market Revenue and Forecast, by Application (2017-2030)

14.4.4. Market Revenue and Forecast, by End-User (2017-2030)

14.4.5. Market Revenue and Forecast, by Gender (2017-2030)

14.4.6. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.7.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.4.7.3. Market Revenue and Forecast, by Application (2017-2030)

14.4.7.4. Market Revenue and Forecast, by End-User (2017-2030)

14.4.8. Market Revenue and Forecast, by Gender (2017-2030)

14.4.9. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Application (2017-2030)

14.4.10.4. Market Revenue and Forecast, by End-User (2017-2030)

14.4.11. Market Revenue and Forecast, by Gender (2017-2030)

14.4.12. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.13.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.4.13.3. Market Revenue and Forecast, by Application (2017-2030)

14.4.13.4. Market Revenue and Forecast, by End-User (2017-2030)

14.4.13.5. Market Revenue and Forecast, by Gender (2017-2030)

14.4.13.6. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.14.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.4.14.3. Market Revenue and Forecast, by Application (2017-2030)

14.4.14.4. Market Revenue and Forecast, by End-User (2017-2030)

14.4.14.5. Market Revenue and Forecast, by Gender (2017-2030)

14.4.14.6. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.5.3. Market Revenue and Forecast, by Application (2017-2030)

14.5.4. Market Revenue and Forecast, by End-User (2017-2030)

14.5.5. Market Revenue and Forecast, by Gender (2017-2030)

14.5.6. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.7.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.5.7.3. Market Revenue and Forecast, by Application (2017-2030)

14.5.7.4. Market Revenue and Forecast, by End-User (2017-2030)

14.5.8. Market Revenue and Forecast, by Gender (2017-2030)

14.5.8.1. Market Revenue and Forecast, by Route of Administration (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Procedure (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Application (2017-2030)

14.5.9.4. Market Revenue and Forecast, by End-User (2017-2030)

14.5.9.5. Market Revenue and Forecast, by Gender (2017-2030)

14.5.9.6. Market Revenue and Forecast, by Route of Administration (2017-2030)

Chapter 15. Company Profiles

15.1. AbbVie Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Galderma

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Alma Lasers

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Cynosure

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Johnson & Johnson Private Limited

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Lumenis Be Ltd.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Solta Medical

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Candela Medical

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Hologic, Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Dentsply Sirona

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com